Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes

Biochimica Et Biophysica Acta
Luca NardoFrancesco Mantegazza

Abstract

Amyloid β (Aβ) peptide aggregation is the main molecular mechanism underlying the development of Alzheimer's disease, the most widespread form of senile dementia worldwide. Increasing evidence suggests that the key factor leading to impaired neuronal function is accumulation of water-soluble Aβ oligomers rather than formation of the senile plaques created by the deposition of large fibrillary aggregates of Aβ. However, several questions remain about the preliminary steps and the progression of Aβ oligomerization. We show that the initial stages of the aggregation of fluorescently labeled Aβ can be determined with a high degree of precision and at physiological (i.e., nanomolar) concentrations by using either steady-state fluorimetry or time-correlated single-photon counting. We study the dependence of the oligomerization extent and rate on the Aβ concentration. We determine the chemical binding affinity of fluorescently labeled Aβ for liposomes that have been recently shown to be pharmacologically active in vivo, reducing the Aβ burden within the brain. We also probe their capacity to hinder the Aβ oligomerization process in vitro. We introduced a fluorescence assay allowing investigation of the earliest steps of Aβ oligomeriza...Continue Reading

References

Jul 1, 1969·Journal of Clinical Pathology·J H Cooper
Mar 21, 2003·The Journal of Biological Chemistry·Tadato BanYuji Goto
Aug 5, 2003·Analytical Biochemistry·Joseph R LakowiczIgnacy Gryczynski
Nov 5, 2003·Biochemistry·Brett A ChromyWilliam L Klein
Sep 3, 2005·Neurobiology of Disease·Ruitian LiuMichael R Sierks
Feb 6, 2007·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Graham HungerfordRui L Reis
Jul 26, 2008·Nature Nanotechnology·Daniel J Müller, Yves F Dufrêne
Oct 7, 2008·Journal of Molecular Biology·Mingfeng Yang, David B Teplow
Nov 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Xiaoyan HuJin-Moo Lee
Apr 13, 2010·Nature Structural & Molecular Biology·Mahiuddin AhmedSteven O Smith
Jun 18, 2010·Biomaterials·Marco GobbiMassimo E Masserini
Oct 6, 2010·Alzheimer Disease and Associated Disorders·Chiara Paola ZoiaCarlo Ferrarese
Jan 5, 2011·International Journal of Alzheimer's Disease·Aaron Y Lai, Joanne McLaurin
Mar 5, 2011·Physical Chemistry Chemical Physics : PCCP·Mariana AmaroOlaf J Rolinski
Feb 9, 2012·Cold Spring Harbor Perspectives in Medicine·Dennis SelkoeDavid Holtzman
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Lennart Mucke, Dennis J Selkoe
Aug 22, 2012·Cold Spring Harbor Perspectives in Medicine·Richard Mayeux, Yaakov Stern
Dec 3, 2014·Nanomedicine : Nanotechnology, Biology, and Medicine·Lara Ordóñez-GutiérrezFrancisco Wandosell
Jun 2, 2015·Translational Neurodegeneration·Fan ZhangXiongwei Zhu
Sep 12, 2015·Nucleic Acids Research·Luca NardoFrancesco Mantegazza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.